Literature DB >> 8770904

Structural features of thyroid hormone response elements that increase susceptibility to inhibition by an RTH mutant thyroid hormone receptor.

A M Zavacki1, J W Harney, G A Brent, P R Larsen.   

Abstract

The chicken lysozyme silencer F2 (F2) thyroid hormone response element (TRE) contains an unusual everted palindromic arrangement, has a high affinity for thyroid hormone receptor (TR) homodimers, and is especially sensitive to dominant negative inhibition by, the T3 resistance (RTH) mutant TR beta P453H. We used various TREs and TR mutations to determine the mechanisms for this sensitivity. Changing the F2 orientation from an everted palindrome to a direct repeat with a 4-bp gap (DR+4) (F2-DR) decreased the sensitivity to inhibition at high T3 concentrations, while a loss of this sensitivity occurred with a palindromic arrangement of these same half-sites. F2 contains the dinucleotide TG 5' to each consensus half-site conforming to the optimal TR-binding octamer, YRRGGTCA. A T to A change in position 1 of both F2 half-sites markedly reduced T3-induction, yet only slightly reduced TR homodimer or TR-retinoid X receptor (RXR) heterodimer binding. The TR beta ninth heptad mutation, L428R, prevents TR heterodimerization with RXR and eliminates the inhibitory effect of the P453H mutant TR on the F2-DR, but not the F2 element. Structural features of a TRE that favor strong TR binding of both TR homodimers and TR-RXR heterodimers containing the mutant TR, such as the everted palindromic conformation or the optimal TR-binding consensus octamer, enhance the sensitivity of a TRE to inhibition by the mutant TR. Thus, both half-site orientation and sequence contribute to the sensitivity of a given TRE to dominant negative inhibition by a mutant TR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8770904     DOI: 10.1210/endo.137.7.8770904

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Activation of the orphan receptor RIP14 by retinoids.

Authors:  A M Zavacki; J M Lehmann; W Seol; T M Willson; S A Kliewer; D D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Cloning and characterization of two novel thyroid hormone receptor beta isoforms.

Authors:  G R Williams
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

3.  TRIIODOTHYRONINE ACTIVATES GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE 3 VIA AGGTCA-LIKE-DIRECT-REPEAT-4 TYPE THYROID HORMONE RESPONSE ELEMENT.

Authors:  L F Zhao; Y Iwasaki; B L Han; J Wang; Y Zhang; J Han; G Y Liu; X Jiang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Apr-Jun       Impact factor: 0.877

4.  Analysis of thyroid response element activity during retinal development.

Authors:  Nathan A Billings; Mark M Emerson; Constance L Cepko
Journal:  PLoS One       Date:  2010-10-29       Impact factor: 3.240

5.  The rat thyroid hormone receptor (TR) Deltabeta3 displays cell-, TR isoform-, and thyroid hormone response element-specific actions.

Authors:  Clare B Harvey; J H Duncan Bassett; Padma Maruvada; Paul M Yen; Graham R Williams
Journal:  Endocrinology       Date:  2007-01-11       Impact factor: 4.736

6.  Thyroid hormone receptor mutations in cancer and resistance to thyroid hormone: perspective and prognosis.

Authors:  Meghan D Rosen; Martin L Privalsky
Journal:  J Thyroid Res       Date:  2011-06-08

Review 7.  New insights on thyroid hormone mediated regulation of herpesvirus infections.

Authors:  Robert W Figliozzi; Feng Chen; S Victor Hsia
Journal:  Cell Biosci       Date:  2017-03-21       Impact factor: 7.133

8.  Thyroid hormone regulates glutamine metabolism and anaplerotic fluxes by inducing mitochondrial glutamate aminotransferase GPT2.

Authors:  Annunziata Gaetana Cicatiello; Serena Sagliocchi; Annarita Nappi; Emery Di Cicco; Caterina Miro; Melania Murolo; Mariano Stornaiuolo; Monica Dentice
Journal:  Cell Rep       Date:  2022-02-22       Impact factor: 9.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.